Anand Doraiswamy

Koya, Inc. engages in the development of wearable therapeutic platform and devices to treat chronic vascular diseases. The company was founded by Andy Doraiswamy and is headquartered in San Francisco, CA.

Koya Medical, Inc. is a privately held healthcare company founded in 2018 with the aim of transforming lymphatic and vein care through innovative patient-centric platforms. Koya Medical is based in Oakland, CA. The company is developing breakthrough treatments for venous diseases and lymphedema, and personalized care that is unavailable with traditional treatments. The company's first treatment, Dayspring, is a mobility-enabled active compression system that provides a treatment solution for lymphedema and CVI patients that won't interfere with their daily life. Anand Doraiswamy founded the company in 2018 and has been the CEO since then.

The American company was founded by a practicing urologist with the aim of developing the preferred first-line device therapy for benign prostatic hyperplasia. The company's flagship product, the Flostent system, enables physicians to treat patients safely and efficiently, with minimal discomfort and reduced complications. Rivermark Medical plans to bring the Flostent system to market as their first product. The CEO of the company is Adam Kadlec.